Papers

Oct 25, 2021

E-PASS scoring system serves as a predictor of short- and long-term outcomes in gastric cancer surgery.

Surgery today
  • Koki Nakanishi
  • Mitsuro Kanda
  • Seiji Ito
  • Yoshinari Mochizuki
  • Hitoshi Teramoto
  • Kiyoshi Ishigure
  • Toshifumi Murai
  • Takahiro Asada
  • Akiharu Ishiyama
  • Hidenobu Matsushita
  • Daisuke Kobayashi
  • Dai Shimizu
  • Chie Tanaka
  • Michitaka Fujiwara
  • Kenta Murotani
  • Yasuhiro Kodera
  • Display all

Volume
52
Number
6
First page
914
Last page
922
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1007/s00595-021-02394-3

PURPOSES: This study aimed to evaluate the estimation of the physiological ability and surgical stress (E-PASS) scoring system for predicting the short- and long-term outcomes in gastric cancer (GC) surgery. METHODS: We analyzed a multi-institutional dataset to study patients who underwent gastrectomy with a curative intent between 2010 and 2014. This study evaluated the associations between the optimal E-PASS score cutoff value and the following outcomes: (1) the incidence of postoperative complications in stage I-III GC patients and (2) the prognosis in stage II-III GC patients. RESULTS: A total of 2495 GC patients were included. A cutoff value of 0.419 was determined using the ROC curve analysis. Postoperative complications were observed more frequently in the E-PASS-high group than that in the E-PASS-low group (30% vs. 17%, p < 0.0001). Among pStage II-III GC patients (n = 1009), the overall survival time of the E-PASS-high group was significantly shorter than that of the E-PASS-low group (hazard ratio 2.08; 95% confidence interval 1.64-2.65; p < 0.0001). A forest plot revealed that E-PASS-high was associated with a greater prognostic factor for overall survival in most subgroups. CONCLUSIONS: The E-PASS scoring system may therefore be a useful predictor of the short- and long-term outcomes in patients with GC who have undergone radical gastrectomy.

Link information
DOI
https://doi.org/10.1007/s00595-021-02394-3
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34694494
ID information
  • DOI : 10.1007/s00595-021-02394-3
  • Pubmed ID : 34694494

Export
BibTeX RIS